Regulus Therapeutics Statistics

Total Valuation

RGLS has a market cap or net worth of $96.29 million. The enterprise value is $10.22 million.

Market Cap	96.29M
Enterprise Value	10.22M

Important Dates

The last earnings date was Thursday, November 7, 2024, after market close.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	n/a

Share Statistics

RGLS has 65.50 million shares outstanding. The number of shares has increased by 148.48% in one year.

Current Share Class	65.50M
Shares Outstanding	65.50M
Shares Change (YoY)	+148.48%
Shares Change (QoQ)	+1.56%
Owned by Insiders (%)	1.69%
Owned by Institutions (%)	64.37%
Float	48.66M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.11
P/TBV Ratio	1.11
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 14.14, with a Debt / Equity ratio of 0.01.

Current Ratio	14.14
Quick Ratio	13.47
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-172.18

Financial Efficiency

Return on equity (ROE) is -72.36% and return on invested capital (ROIC) is -46.31%.

Return on Equity (ROE)	-72.36%
Return on Assets (ROA)	-42.39%
Return on Capital (ROIC)	-46.31%
Revenue Per Employee	n/a
Profits Per Employee	-$1.39M
Employee Count	30
Asset Turnover	n/a
Inventory Turnover	7.25

Taxes

In the past 12 months, RGLS has paid $1,000 in taxes.

Income Tax	1,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +7.30% in the last 52 weeks. The beta is 1.63, so RGLS's price volatility has been higher than the market average.

Beta (5Y)	1.63
52-Week Price Change	+7.30%
50-Day Moving Average	1.53
200-Day Moving Average	1.88
Relative Strength Index (RSI)	48.95
Average Volume (20 Days)	491,329

Short Selling Information

The latest short interest is 1.69 million, so 2.58% of the outstanding shares have been sold short.

Short Interest	1.69M
Short Previous Month	2.50M
Short % of Shares Out	2.58%
Short % of Float	3.47%
Short Ratio (days to cover)	4.24

Income Statement

Revenue	n/a
Gross Profit	-22.62M
Operating Income	-44.59M
Pretax Income	-35.39M
Net Income	-41.63M
EBITDA	-44.26M
EBIT	-44.59M
Earnings Per Share (EPS)	-$0.92

Full Income Statement

Balance Sheet

The company has $87.31 million in cash and $1.24 million in debt, giving a net cash position of $86.07 million or $1.31 per share.

Cash & Cash Equivalents	87.31M
Total Debt	1.24M
Net Cash	86.07M
Net Cash Per Share	$1.31
Equity (Book Value)	86.81M
Book Value Per Share	1.33
Working Capital	85.21M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$35.95 million and capital expenditures -$411,000, giving a free cash flow of -$36.36 million.

Operating Cash Flow	-35.95M
Capital Expenditures	-411,000
Free Cash Flow	-36.36M
FCF Per Share	-$0.56

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RGLS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-148.48%
Shareholder Yield	-148.48%
Earnings Yield	-43.23%
FCF Yield	-37.77%

Analyst Forecast

The average price target for RGLS is $10.33, which is 602.72% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$10.33
Price Target Difference	602.72%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on June 29, 2022. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Jun 29, 2022
Split Type	Reverse
Split Ratio	0.1:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2